PREVALENCE OF PULMONARY HYPERTENSION IN PATIENTS OF CHRONIC KIDNEY DISEASE IN WESTERN RAJASTHAN: A CROSS-SECTIONAL STUDY

Authors

  • SWATI VYAS Department of General Medicine, Government Medical College, Kota, Rajasthan, India.
  • POOJA YADAV Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.
  • AGRAWAL RP Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i9.45454

Keywords:

Chronic kidney disease, Pulmonary hypertension, Stage

Abstract

Objective: We organized a study to determine the prevalence of pulmonary hypertension (PHT) in individuals with chronic renal disease, because there has not been much research on this topic in our area. Studying any relationships, if any, between PHT and chronic kidney disease (CKD) stage was another goal.

Methods: A hospital-based cross-sectional study of 108 CKD cases was carried out (according to various phases based on glomerular filtration rate) and included participants over the age of 18. SPSS software was used to collect and analyze all data. Correlation was determined using the corelation coefficient.

Results: About 15.74% of people with CKD had PHT. Patients’ PHT was mild in 47.06% of cases, moderate in 41.18% of cases, and severe in 11.11% of cases. The correlation between the stage of CKD and PHT was determined to be statistically negligible. Age, CKD stage and duration, and PAH were revealed to be statistically unimportant in linear regression.

Conclusion: About 15.74% of CKD patients had PHT, according to the study. The age of the patients, the length of the CKD, and the stage of the CKD were positively correlated with PHT.

Downloads

Download data is not yet available.

Author Biographies

SWATI VYAS, Department of General Medicine, Government Medical College, Kota, Rajasthan, India.

Senior Resident, Department of General Medicine, Sardar Patel Medical College, Bikaner

POOJA YADAV, Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.

Senior Resident, Department of General Medicine, Govt. Medical College, Kota

AGRAWAL RP, Department of General Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.

Senior Professor, Department of General Medicine, Sardar Patel Medical College, Bikaner

References

Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: The challenge continues. Registro lombardo dialisi e trapianto Nephrol Dial Transplant 2000;5:69-80. doi: 10.1093/ndt/15.suppl_5.69, PMID 11073278.

Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998;338:1428-37. doi: 10.1056/NEJM199805143382006.

Barak M, Katz Y. Microbubbles: Pathophysiology and clinical implications. Chest 2005;128:2918-32. doi: 10.1378/chest.128.4.2918, PMID 16236969.

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: Results from a national registry. Am J Respir Crit Care Med 2006;173:1023-30. doi: 10.1164/ rccm.200510-1668OC, PMID 16456139.

Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: Prevalence and relation tosplanchnic hemodynamics. Gastroenterology 1991;100:520-8. doi: 10.1016/0016-5085(91)90225-a, PMID 1985048.

Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology 2006;44:1502-10. doi: 10.1002/hep.21431, PMID 17133488.

Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 2009;75:969-75. doi: 10.1038/ ki.2009.10, PMID 19212417.

Tarrass F, Benjelloun M, Hachim K, Benghanem MG, Ramdani B. Pulmonary hypertension in patients with end-stage renal disease. Indian J Nephrol 2005;15:223-6.

Moniruzzaman M, Islam MN, Alam MB, Alam AM, Khan MM, Ali Z, et al. Pulmonary hypertension in hemodialysis patients. Cardiovasc J 2014;4:148-52. doi: 10.3329/cardio.v4i2.10459.

Abraham G, Pratap B, Ramalakshmi R, Mathew M, Jeevan J, Muralidharan T, et al. Clinical and biochemical parameters in chronic kidney disease with pulmonary hypertension. Indian J Nephrol 2007;17:4-6. doi: 10.4103/0971-4065.35012.

Gokul R. Replacement therapy by dialysis. In: Weatherall DJ, Ledingham JG, Warrell DA, editors. Oxford Textbook of Medicine. 3rd ed. Oxford: Oxford University Press; 1996. p. 3306-10.

Yigla M, Dabbah S, Azzam ZS, Rubin AH, Reisner SA. Background diseases in 671 patients with moderate to severe pulmonary hypertension. Isr Med Assoc J 2000;2:684-9. PMID 11062769.

Mahdavi-Mazdeh M, Alijavad-Mousavi S, Yahyazadeh H, Azadi M, Yoosefnejad H, Ataiipoor Y. Pulmonary hypertension in hemodialysis patients. Saudi J Kidney Dis Transpl 2008;19:189-93. PMID 18310865.

van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 1997;2:14-8 PMID 9269693.

Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W, et al. Pulmonary hypertension: Epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS One 2014;9:e114392. doi: 10.1371/journal.pone.0114392, PMID 25525807.

Published

07-09-2022

How to Cite

VYAS, S., P. YADAV, and A. RP. “PREVALENCE OF PULMONARY HYPERTENSION IN PATIENTS OF CHRONIC KIDNEY DISEASE IN WESTERN RAJASTHAN: A CROSS-SECTIONAL STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 9, Sept. 2022, pp. 202-4, doi:10.22159/ajpcr.2022.v15i9.45454.

Issue

Section

Original Article(s)